Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial

INTRODUCTION: The effectiveness of umifenovir against COVID-19 is controversial; therefore, clinical trials are crucial to evaluate its efficacy. METHODS: The study was conducted as a single-center, randomized, open-label clinical trial. Eligible moderate-severe hospitalized patients with confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi Darazam, Ilad, Shokouhi, Shervin, Mardani, Masoud, Pourhoseingholi, Mohamad Amin, Rabiei, Mohammad Mahdi, Hatami, Firouze, Shabani, Minoosh, Moradi, Omid, Gharehbagh, Farid Javandoust, Irvani, Seyed Sina Naghibi, Amirdosara, Mahdi, Hajiesmaeili, Mohammadreza, Rezaei, Omidvar, Khoshkar, Ali, Lotfollahi, Legha, Gachkar, Latif, Dehbsneh, Hadiseh Shabanpour, Khalili, Negar, Soleymaninia, Azam, Kusha, Akram Hoseyni, Shoushtari, Maryam Taleb, Torabinavid, Parham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270750/
https://www.ncbi.nlm.nih.gov/pubmed/34273635
http://dx.doi.org/10.1016/j.intimp.2021.107969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270750/
https://www.ncbi.nlm.nih.gov/pubmed/34273635
http://dx.doi.org/10.1016/j.intimp.2021.107969

Ejemplares similares